Keywords

• Appeal
• Competition
• Abuse of dominant position
• Market in anti-ulcer medicines
• Abuse of procedures relating to supplementary protection certificates for medicinal products and of marketing authorisation procedures for medicinal products
• Misleading representations
• Deregistration of marketing authorisations
• Obstacles to the marketing of generic medicinal products and to parallel imports.